Conferences
ASCO
Breast Cancer
GI Cancer
GU Cancer
Head and Neck Cancer
Hematology
Lung Cancer
Rapid Reactions
ASCO GI
Biliary/Liver Cancer
Colorectal Cancer
Gastric/GEJ Cancer
General GI Cancer
Pancreatic Cancer
ASCO GU
Bladder Cancer
General GU Oncology
Prostate Cancer
RCC
ASH
General Hematology
Leukemia
Lymphoma
Multiple Myeloma
EHA
Leukemia
Lymphoma
Multiple Myeloma
Rapid Reactions
ESMO
Breast Cancer
GI Oncology
GU Oncology
Lung Cancer
Rapid Reactions
IMS
Multiple Myeloma
SABCS
General Breast Cancer
HER2-Positive Breast Cancer
HR+ Disease
TNBC
SOHO
Leukemia
Rapid Reactions
WCLC
NSCLC
SCLC
Rapid Reactions
Videos & Podcasts
Treatment Algorithms
Breast Cancer
Dermatology
GI Oncology
GU Cancer
Head and Neck Cancers
Hematology
Lung Cancer
Ovarian Cancer
New Approvals
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Tox Check
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Challenging Cases
Breast Cancer
GU Oncology
Hematology
Lung Cancer
Partners in Practice
Hematology
Pancreatic Cancer
Clinical Foundations
Hematology
Rapid Fire Rounds
Hematology
Clinical Foundations
Expert Interviews
Clinical Insights
Breast Cancer
ctDNA
Early HR+
Metastatic HR+
GI Oncology
Gastric/GEJ Cancer
Pancreatic Cancer
GU Oncology
Bladder Cancer
RCC
Head & neck cancers
Hematology
Leukemia
Lymphoma
MDS
Multiple Myeloma
Polycythemia Vera
Lung Cancer
NSCLC
SCLC
Resource Centers
Cell Therapy
HER2-Positive GI Cancer
Metastatic Breast Cancer
Pancreatic Cancer
Articles
Breast Cancer
General News
GI Oncology
GU Oncology
Hematology
Lung Cancer
Events
Subscribe
Conferences
ASCO
Breast Cancer
GI Cancer
GU Cancer
Head and Neck Cancer
Hematology
Lung Cancer
Rapid Reactions
ASCO GI
Biliary/Liver Cancer
Colorectal Cancer
Gastric/GEJ Cancer
General GI Cancer
Pancreatic Cancer
ASCO GU
Bladder Cancer
General GU Oncology
Prostate Cancer
RCC
ASH
General Hematology
Leukemia
Lymphoma
Multiple Myeloma
EHA
Leukemia
Lymphoma
Multiple Myeloma
Rapid Reactions
ESMO
Breast Cancer
GI Oncology
GU Oncology
Lung Cancer
Rapid Reactions
IMS
Multiple Myeloma
SABCS
General Breast Cancer
HER2-Positive Breast Cancer
HR+ Disease
TNBC
SOHO
Leukemia
Rapid Reactions
WCLC
NSCLC
SCLC
Rapid Reactions
Videos & Podcasts
Treatment Algorithms
Breast Cancer
Dermatology
GI Oncology
GU Cancer
Head and Neck Cancers
Hematology
Lung Cancer
Ovarian Cancer
New Approvals
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Tox Check
Breast Cancer
GI Oncology
GU Oncology
Hematology
Lung Cancer
Challenging Cases
Breast Cancer
GU Oncology
Hematology
Lung Cancer
Partners in Practice
Hematology
Pancreatic Cancer
Clinical Foundations
Hematology
Rapid Fire Rounds
Hematology
Clinical Foundations
Expert Interviews
Clinical Insights
Breast Cancer
ctDNA
Early HR+
Metastatic HR+
GI Oncology
Gastric/GEJ Cancer
Pancreatic Cancer
GU Oncology
Bladder Cancer
RCC
Head & neck cancers
Hematology
Leukemia
Lymphoma
MDS
Multiple Myeloma
Polycythemia Vera
Lung Cancer
NSCLC
SCLC
Resource Centers
Cell Therapy
HER2-Positive GI Cancer
Metastatic Breast Cancer
Pancreatic Cancer
Articles
Breast Cancer
General News
GI Oncology
GU Oncology
Hematology
Lung Cancer
Events
Subscribe
Jimmitti Teysir, MD
Memorial Sloan Kettering Cancer Center
Latest Content
Conferences
06/12/2026
How Molecular Profiling Guides Targeted Therapy Options in HR–Positive Breast Cancer
Jimmitti Teysir, MD
Ya Haddy Sallah, MD, MPH